# US 2019/0170736 A1 · Systems including janus droplets

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0170736 A1
- Document ID: US20190170736A1
- Status: Published application
- Kind: A1
- Application number: 16/201,961
- Filed: 2018-11-27
- Published: 2019-06-06
- Earliest claimed: 2014-10-31
- Assignees: Massachusetts Institute of Technology
- Applicants: Massachusetts Institute of Technology
- Inventors: Timothy M. Swager; Qifan Zhang
- Web page: https://patentgrep.com/patent/US20190170736A1

## CPC

- G01N 33/5432: {Liposomes or microcapsules}
- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- G01N 21/59: Transmissivity (G01N21/25 takes precedence)
- G01N 21/77: by observing the effect on a chemical indicator
- G01N 33/54326: {Magnetic particles}
- G01N 33/54366: {Apparatus specially adapted for solid-phase testing}
- G01N 21/78: producing a change of colour
- G01N 2021/7783: {Transmission, loss}
- G01N 2201/0221: Portable; cableless; compact; hand-held
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Embodiments described herein may be useful in the detection of analytes. The systems and methods may allow for a relatively simple and rapid way for detecting analytes such as chemical and/or biological analytes and may be useful in numerous applications including sensing, food manufacturing, medical diagnostics, performance materials, dynamic lenses, water monitoring, environmental monitoring, detection of proteins, detection of DNA, among other applications. For example, the systems and methods described herein may be used for determining the presence of a contaminant such as bacteria (e.g., detecting pathogenic bacteria in food and water samples which helps to prevent widespread infection, illness, and even death). Advantageously, the systems and methods described herein may not have the drawbacks in current detection technologies including, for example, relatively high costs, long enrichment steps and analysis times, and/or the need for extensive user training. Another advantageous feature provided by the systems and methods described herein includes fabrication in a relatively large scale. In some embodiments, the systems and methods may be used in conjunction with a detector including handheld detectors incorporated with, for example, smartphones (e.g., for the on-site detection of analytes such as pathogenic bacteria).

## Claims

### Claim 1

A system comprising: a plurality of Janus droplets comprising a first phase and a second phase; and
an amphiphilic compound associated with the first phase and capable of interacting with a biological analyte,
wherein the amphiphilic compound does not associate with the second phase, and

### Claim 2 (depends on 1)

A system as in claim 1, wherein the amphiphilic compound comprises gallic acid or a derivative thereof.

### Claim 3 (depends on 1)

A system as in claim 1, wherein upon binding to the biological analyte, at least a portion of the plurality of Janus droplets agglutinate.

### Claim 4 (depends on 1)

A system as in claim 1, wherein, prior to binding to the biological analyte, the plurality of Janus droplets are oriented such that at least a portion of interfaces between a first phase and a second phase within each Janus droplet are aligned parallel with respect to one another.

### Claim 5

A system comprising:
an outer phase; and
a plurality of droplets dispersed within the outer phase, wherein at least a portion of the plurality of droplets comprise a first phase and a second phase, the first phase immiscible with the second phase; and
an amphiphilic compound associated with the first phase, the amphiphilic compound capable of binding with a biological analyte,
wherein the plurality of droplets have a first configuration in which the amphiphilic compound is exposed to the outer phase, and
wherein the plurality of droplets have a second configuration in which the amphiphilic compound is not exposed to the outer phase.

### Claim 6

A method, comprising:
providing a colloid comprising:
an outer phase;
a plurality of droplets dispersed within the outer phase, wherein at least a portion of the plurality of droplets comprise a first phase and a second phase, the first phase immiscible with the second phase; and
an amphiphilic compound associated with the first phase, the amphiphilic compound capable of binding with a biological analyte, wherein the amphiphilic compound is not exposed to the outer phase;
stimulating the colloid, such that the first phase and the second phase change arrangement and such that the amphiphilic compound is exposed to the outer phase and wherein the first phase and the second phase are immiscible with each other after changing arrangement.

### Claim 7

A method comprising:
allowing a biological analyte to bind to an amphiphilic compound associated with a plurality of Janus droplets; and
determining a change in electromagnetic radiation interacting with the plurality of Janus droplets due at least in part to the binding of the biological analyte to the amphiphilic compound.

### Claim 8

A method for determining an analyte, comprising:
exposing, to an article comprising an outer phase and a plurality of Janus droplets dispersed within the outer phase, a chemical or biological analyte, wherein the chemical or biological analyte, if present, interacts with an amphiphilic compound associated with a first phase of the Janus droplets such that at least a portion of the plurality of Janus droplets change orientation thereby producing a detectable change in an optical property of the article; and
determining the detectable change.

### Claim 9 (depends on 8)

A method as in claim 8, wherein interacting with at least a portion of the article comprises binding of the chemical or biological analyte to the amphiphilic compound.

### Claim 10 (depends on 8)

A method as in claim 8, wherein, prior to exposing the article to a chemical or biological analyte, at least a portion of the plurality of Janus droplets are oriented such that at least a portion of interfaces between a first phase and a second phase within each Janus droplet are aligned parallel with respect to one another.

### Claim 11 (depends on 10)

A method as in claim 10, wherein substantially all of the interfaces between a first phase and a second phase within each Janus droplet are aligned parallel with respect to one another.

### Claim 12 (depends on 8)

A method as in claim 8, wherein, upon exposing the article to a chemical or biological analyte, at least a portion of the plurality of Janus droplets agglutinate.

### Claim 13 (depends on 8)

A method as in claim 8, wherein, upon exposing the article to a chemical or biological analyte, at least a portion of the plurality of Janus droplets are oriented such that at least a portion of interfaces between a first phase and a second phase within each Janus droplet are not aligned parallel with respect to one another.

### Claim 14 (depends on 1)

A system as in claim 1, comprising;
a source of external energy applicable to the composition to generate a determinable signal; and
a detector positioned to detect the signal.

### Claim 15 (depends on 14)

A system as in claim 14, wherein the signal comprises electromagnetic radiation.

### Claim 16 (depends on 14)

A system as in claim 14, wherein, upon exposure of the article to a chemical or biological analyte, the system generates the determinable signal.

### Claim 17 (depends on 1)

A system as in claim 1, wherein each Janus droplet comprises a first phase and a second phase, immiscible with the first phase.

### Claim 18 (depends on 1)

A system as in claim 1, wherein the outer phase is an aqueous phase.

### Claim 19 (depends on 1)

A system as in claim 1, wherein the first phase comprises a hydrocarbon, a fluorocarbon, a silicone, a liquid crystal, an ionic liquid, a polymer, a block copolymer, combinations thereof, or derivatives thereof.

### Claim 20 (depends on 1)

A system as in claim 1, wherein the second phase comprises a hydrocarbon, a fluorocarbon, a silicone, a liquid crystal, an ionic liquid, a polymer, a block copolymer, combinations thereof, or derivatives thereof, immiscible with the first phase.

### Claim 21 (depends on 1)

A system as in claim 1, wherein the amphiphilic compound is selected from the group consisting of: ionic surfactants, non-ionic surfactants, zwitterionic surfactants, polymers, proteins, DNA, RNA, acids, carbohydrates, saccharides, enzymes, chromophores, lipids, graphene oxide, combinations thereof, nanoparticles, and derivatives thereof.

### Claim 22 (depends on 1)

A system as in claim 1, wherein the analyte comprises a biological compound, a drug, a macromolecule, a salt, an electrolyte, an enzyme, an acid, a nucleic acid, a carbohydrate, a peptide, a protein, a phosphate, a sulfonate, a virus, a pathogen, an oxidant, a reductant, a toxin, a chemical warfare agent, an explosive, carbon dioxide, or combinations thereof.

### Claim 23 (depends on 1)

A system as in claim 1, wherein the amphiphilic compound is gallic acid or a derivative thereof.
